|
|
|
Insider
Information: |
Sachdev Amit |
Relationship: |
|
City: |
Cambridge |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
71,325 |
|
Indirect Shares
|
7,447 |
|
|
Direct
Value |
$26,276,609 |
|
|
Indirect Value
|
$3,536,953 |
|
|
Total
Shares |
78,772 |
|
|
Total
Value |
$29,813,561 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Vertex Pharmaceuticals Inc |
VRTX |
EVP Chief Patient & Ex... |
2024-05-15 |
55,325 |
2024-05-15 |
7,447 |
Premium* |
|
Celladon Corp |
CLDN |
|
2022-03-11 |
16,000 |
2020-03-12 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
193 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-11-16 |
4 |
AS |
$41.29 |
$94,430 |
D/D |
(2,287) |
18,821 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-01-19 |
4 |
AS |
$37.00 |
$150,442 |
D/D |
(4,066) |
35,008 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-12-12 |
4 |
AS |
$65.47 |
$166,425 |
D/D |
(2,542) |
26,561 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-07-16 |
4 |
OE |
$96.87 |
$166,520 |
D/D |
1,719 |
48,381 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-05 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
48,603 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-08-03 |
4 |
OE |
$86.52 |
$167,935 |
D/D |
1,941 |
37,044 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-03 |
4 |
OE |
$86.52 |
$168,022 |
D/D |
1,942 |
48,604 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Public Policy,Gov Affairs |
|
2010-10-26 |
4 |
AS |
$37.50 |
$170,025 |
D/D |
(4,534) |
44,910 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-03-03 |
4 |
OE |
$18.93 |
$180,422 |
D/D |
9,531 |
49,685 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2010-10-28 |
4 |
AS |
$38.50 |
$182,875 |
D/D |
(4,750) |
40,160 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2020-05-06 |
4 |
AS |
$275.28 |
$184,162 |
D/D |
(669) |
35,103 |
0 |
% |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-02-26 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-02 |
4 |
OE |
$91.05 |
$196,213 |
D/D |
2,155 |
48,817 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-01-18 |
4 |
OE |
$18.93 |
$225,532 |
D/D |
11,914 |
51,752 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2011-02-28 |
4 |
OE |
$18.93 |
$225,551 |
D/D |
11,915 |
56,041 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Global Gov. Strategy |
|
2013-07-11 |
4 |
OE |
$33.28 |
$232,960 |
D/D |
7,000 |
35,987 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-14 |
4 |
OE |
$32.16 |
$306,517 |
D/D |
9,531 |
30,639 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-09-21 |
4 |
OE |
$32.16 |
$306,517 |
D/D |
9,531 |
30,639 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-07-16 |
4 |
AS |
$180.14 |
$310,042 |
D/D |
(1,719) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2019-10-22 |
4 |
OE |
$86.52 |
$335,957 |
D/D |
3,883 |
37,299 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, Chief Patient Officer |
|
2021-04-27 |
4 |
OE |
$86.52 |
$336,044 |
D/D |
3,884 |
44,017 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-11-05 |
4 |
AS |
$172.70 |
$337,204 |
D/D |
(1,941) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
EVP, CRO |
|
2018-08-03 |
4 |
AS |
$174.50 |
$340,050 |
D/D |
(1,942) |
46,662 |
0 |
- |
|
VRTX |
Vertex Pharmaceuticals In... |
SVP, Corp Affairs & Pub Policy |
|
2012-03-30 |
4 |
OE |
$18.93 |
$360,844 |
D/D |
19,062 |
60,170 |
0 |
- |
|
193 Records found
|
|
Page 3 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|